Protein kinase CK2 in health and disease: CK2: the kinase controlling the Hsp90 chaperone machinery
- PMID: 19387550
- PMCID: PMC11115779
- DOI: 10.1007/s00018-009-9152-0
Protein kinase CK2 in health and disease: CK2: the kinase controlling the Hsp90 chaperone machinery
Abstract
CK2 is a ubiquitous and essential protein kinase with pleiotropic substrates and function, but it remains unclear how, when, and where CK2 activity is regulated in cells. Hsp90 is a major molecular chaperone that is required for the folding and function of its client proteins. A complex containing Hsp90 and its client protein includes co-chaperones such as steroid hormone receptor-specific FKBP52 and signaling kinase-specific Cdc37. Co-chaperones work cooperatively with Hsp90 to stabilize client proteins and to keep them in a conformation amenable to activation under appropriate conditions. In this review, critical roles of CK2 in the regulation of the Hsp90-mediated chaperone system are described. CK2 phosphorylates and modulates Hsp90 and its co-chaperones FKBP52 and Cdc37. CK2-dependent phosphorylation of Cdc37 is essential for the chaperoning function of Hsp90-Cdc37 for multiple signaling protein kinases. The tumor kinome appears to become addicted to the Hsp90-Cdc37 chaperone system, thus, targeting Hsp90, Cdc37, and CK2 is a promising strategy for cancer treatment.
Similar articles
-
CK2 binds, phosphorylates, and regulates its pivotal substrate Cdc37, an Hsp90-cochaperone.Mol Cell Biochem. 2005 Jun;274(1-2):171-9. doi: 10.1007/s11010-005-2949-8. Mol Cell Biochem. 2005. PMID: 16335536
-
CK2 controls multiple protein kinases by phosphorylating a kinase-targeting molecular chaperone, Cdc37.Mol Cell Biol. 2004 May;24(9):4065-74. doi: 10.1128/MCB.24.9.4065-4074.2004. Mol Cell Biol. 2004. PMID: 15082798 Free PMC article.
-
Atomistic simulations and network-based modeling of the Hsp90-Cdc37 chaperone binding with Cdk4 client protein: A mechanism of chaperoning kinase clients by exploiting weak spots of intrinsically dynamic kinase domains.PLoS One. 2017 Dec 21;12(12):e0190267. doi: 10.1371/journal.pone.0190267. eCollection 2017. PLoS One. 2017. PMID: 29267381 Free PMC article.
-
Supervision of multiple signaling protein kinases by the CK2-Cdc37 couple, a possible novel cancer therapeutic target.Ann N Y Acad Sci. 2004 Dec;1030:150-7. doi: 10.1196/annals.1329.019. Ann N Y Acad Sci. 2004. PMID: 15659792 Review.
-
Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery.J Hematol Oncol. 2018 Apr 27;11(1):59. doi: 10.1186/s13045-018-0602-8. J Hematol Oncol. 2018. PMID: 29699578 Free PMC article. Review.
Cited by
-
Phosphorylation of CRN2 by CK2 regulates F-actin and Arp2/3 interaction and inhibits cell migration.Sci Rep. 2012;2:241. doi: 10.1038/srep00241. Epub 2012 Jan 31. Sci Rep. 2012. PMID: 22355754 Free PMC article.
-
Protein kinase CK2: a potential therapeutic target for diverse human diseases.Signal Transduct Target Ther. 2021 May 17;6(1):183. doi: 10.1038/s41392-021-00567-7. Signal Transduct Target Ther. 2021. PMID: 33994545 Free PMC article. Review.
-
CK2 and the Hallmarks of Cancer.Biomedicines. 2022 Aug 16;10(8):1987. doi: 10.3390/biomedicines10081987. Biomedicines. 2022. PMID: 36009534 Free PMC article. Review.
-
Autophagosome-mediated EGFR down-regulation induced by the CK2 inhibitor enhances the efficacy of EGFR-TKI on EGFR-mutant lung cancer cells with resistance by T790M.PLoS One. 2014 Dec 8;9(12):e114000. doi: 10.1371/journal.pone.0114000. eCollection 2014. PLoS One. 2014. PMID: 25486409 Free PMC article.
-
P23 Acts as Functional RBP in the Macrophage Inflammation Response.Front Mol Biosci. 2021 Jun 11;8:625608. doi: 10.3389/fmolb.2021.625608. eCollection 2021. Front Mol Biosci. 2021. PMID: 34179071 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous